GENE EDITING

In gene editing, a scientist makes a small controlled change in the DNA of a living organism. This creates only a small change in a hugely complex genome. GMOs, genetically modified organisms are the result of a change in the DNA of a living organism. Gene editing is used for many purposes, including the production of GMOs. However, there are many other different methods of producing GMOs. The current era of genome engineering has been revolutionized by the development of a bacterial adaptive immune system, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) into a radical technology that is making rapid advances in its mechanism, function, and applicability. With enormous potential for profound impact, CRISPR has become a leading method for plausible genomic manipulations in a variety of organisms due to its simplicity, precision, and speed. Scientists have identified genes in mice that regulate lifespan. They then worked on these genes and raised mice that lived a generation longer than their peers. These genes also have their equivalents in the human genome.

Gene editing is being refined day by day and it is foreseeable that one day it will be technically possible to edit the genome of human embryos to extend their lifespan. CRISPR has given us potentially direct access to the source code of life, while also bringing great hope to billions of people. The promising deliverability of the technology is one of the main reasons why so many investors are spending millions of dollars, in fact, the sector that CRISPR belongs to is experiencing a kind of "gold rush" with all investments in dollars. Scientists are working around the clock to reduce the off-target errors that CRISPR brings, and in no time it is being implemented in a clinical setting. CRISPR features a much higher success rate than other nuclease technologies when it involves cutting DNA within the right place. Scientists are working around the clock to reduce the off-target errors that CRISPR brings, and in no time it is being implemented in a clinical setting. CRISPR features a much higher success rate than other nuclease technologies when it involves cutting DNA within the right place.